| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |